Copyright
©The Author(s) 2023.
World J Transplant. Jun 18, 2023; 13(4): 147-156
Published online Jun 18, 2023. doi: 10.5500/wjt.v13.i4.147
Published online Jun 18, 2023. doi: 10.5500/wjt.v13.i4.147
SPK | PAK | PTA | |||||||
Transplant (n = 5834) | Waitlist (n = 3664) | P value | Transplant (n = 430) | Waitlist (n = 681) | P value | Transplant (n = 619) | Waitlist (n = 320) | P value | |
Age at registration (yr) | < 0.001 | 0.04 | 0.68 | ||||||
mean (SD) | 40.1 (8.7) | 41.0 (9.3) | 40.6 (8.9) | 41.8 (9.5) | 41.7 (10.6) | 41.4 (10.8) | |||
Range | 18.0 - 69.0 | 18.0 - 73.0 | 22.0 - 67.0 | 18.0 - 66.0 | 18.0 - 68.0 | 20.0 - 70.0 | |||
Gender | < 0.001 | 0.026 | 0.49 | ||||||
Female | 2284 (39.1%) | 1663 (45.4%) | 174 (40.5%) | 322 (47.3%) | 378 (61.1%) | 188 (58.8%) | |||
Male | 3550 (60.9%) | 2001 (54.6%) | 256 (59.5%) | 359 (52.7%) | 241 (38.9%) | 132 (41.2%) | |||
Race | 0.3 | 0.08 | < 0.001 | ||||||
White | 3732 (64.0%) | 2295 (62.6%) | 336 (78.1%) | 502 (73.7%) | 567 (91.6%) | 263 (82.2%) | |||
Black | 1229 (21.1%) | 781 (21.3%) | 37 (8.6%) | 88 (12.9%) | 25 (4.0%) | 27 (8.4%) | |||
Other | 873 (15.0%) | 588 (16.0%) | 57 (13.3%) | 91 (13.4%) | 27 (4.4%) | 30 (9.4%) | |||
Ethnicity | 0.22 | 0.7 | 0.012 | ||||||
Hispanic/Latino | 714 (12.2%) | 480 (13.1%) | 46 (10.7%) | 78 (11.5%) | 23 (3.7%) | 24 (7.5%) | |||
Non-Hispanic/Non-Latino | 5120 (87.8%) | 3184 (86.9%) | 384 (89.3%) | 603 (88.5%) | 596 (96.3%) | 296 (92.5%) | |||
Karnofsky score at registration | 0.34 | 0.46 | 0.013 | ||||||
High | 3441 (60.7%) | 2151 (61.9%) | 291 (70.3%) | 427 (66.6%) | 392 (64.9%) | 229 (74.1%) | |||
Middle | 2108 (37.2%) | 1259 (36.3%) | 114 (27.5%) | 199 (31.0%) | 195 (32.3%) | 76 (24.6%) | |||
Low | 121 (2.1%) | 63 (1.8%) | 9 (2.2%) | 15 (2.3%) | 17 (2.8%) | 4 (1.3%) | |||
BMI at registration | < 0.001 | 0.038 | 0.82 | ||||||
Normal | 2847 (49.1%) | 1640 (45.2%) | 200 (46.9%) | 287 (42.5%) | 240 (40.1%) | 133 (41.8%) | |||
Underweight | 95 (1.6%) | 60 (1.7%) | 5 (1.2%) | 8 (1.2%) | 11 (1.8%) | 4 (1.3%) | |||
Overweight | 2180 (37.6%) | 1311 (36.2%) | 172 (40.4%) | 259 (38.4%) | 231 (38.6%) | 116 (36.5%) | |||
Obese | 674 (11.6%) | 615 (17.0%) | 49 (11.5%) | 121 (17.9%) | 117 (19.5%) | 65 (20.4%) | |||
Duration of diabetes (yr) | 0.064 | 0.052 | 0.28 | ||||||
mean (SD) | 26.3 (9.0) | 26.6 (9.2) | 26.9 (8.6) | 28.0 (9.5) | 26.6 (11.4) | 25.8 (11.7) | |||
Range | 0.0 - 59.0 | 0.0 - 60.0 | 3.0 - 49.0 | 2.0 - 55.0 | 0.0 - 58.0 | 1.0 - 57.0 | |||
Peripheral vascular disease at registration | < 0.001 | 0.96 | 0.78 | ||||||
No | 5253 (91.5%) | 3136 (87.4%) | 384 (91.0%) | 613 (91.1%) | 545 (89.1%) | 286 (89.7%) | |||
Yes | 488 (8.5%) | 453 (12.6%) | 38 (9.0%) | 60 (8.9%) | 67 (10.9%) | 33 (10.3%) | |||
Time on waitlist (yr) | < 0.001 | < 0.001 | < 0.001 | ||||||
mean (SD) | 0.9 (1.0) | 1.8 (1.7) | 1.2 (1.1) | 2.5 (2.0) | 0.6 (0.8) | 1.9 (1.9) | |||
Range | 0.0 - 7.4 | 0.0 - 10.3 | 0.0 - 5.9 | 0.0 - 9.9 | 0.0 - 6.7 | 0.0 - 10.0 | |||
Follow-up time after transplant (yr) | |||||||||
mean (SD) | 3.7 (2.5) | NA | 3.4 (2.6) | NA | 3.3 (2.5) | NA | |||
Range | 0.0 - 10.1 | NA | 0.0 - 9.1 | NA | 0.0 - 9.1 | NA |
- Citation: Jarmi T, Brennan E, Clendenon J, Spaulding AC. Mortality assessment for pancreas transplants in the United States over the decade 2008-2018. World J Transplant 2023; 13(4): 147-156
- URL: https://www.wjgnet.com/2220-3230/full/v13/i4/147.htm
- DOI: https://dx.doi.org/10.5500/wjt.v13.i4.147